Holder of a Master’s degree in business administration and health economics from the Université catholique de Lille (Catholic University of Lille), he founded Meditech Access in 2012.

Michel is a recognised and experienced expert in the field of health economics, market access, coding (activity-based pricing and PMSI) and reimbursement.

For almost 30 years, he has held positions, both internationally and locally, for the medical device industry, healthcare providers and insurance companies. He has contributed his expertise to renowned companies such as Johnson and Johnson, Baxter, Linde, Allianz/World Aid and Edward Lifesciences. He has successfully managed the financing and reimbursement of groundbreaking innovations such as transcutaneous aortic valves (TAVI) in France, Benelux and Switzerland, resulting in significant TAVI pricing and appropriate care. He has developed an expertise in market access in various therapeutic areas, including diabetes, renal therapies, medical gases, wound healing, pain, respiratory, intensive care, interventional cardiology and e-health.

Qualified pharmacist, Claire joined MediTech Access in 2013 as Market Access Director and is acting as General Manager since 2017. She participates in the definition of the strategy and development objectives of the strategy consulting firm of Market Access. It must guarantee the quality of operation, development, and integrity of the Cabinet while respecting the founding values and guidelines defined by the Presidency.

Claire is recognised as an expert in medical writing. She has extensive experience in reimbursement, gained in positions in French subsidiaries within the healthcare industry. A former attaché at the Paris Hospitals, she then brought her expertise to companies such as Bristol Myers Squibb, Sanofi-Aventis, Baxter and Leo Pharma for the last 15 years. She has also worked as a consultant at Carré Castan Consultants or as a Project Manager at AFSSAPS/ANSM. She has successfully managed the financing and reimbursement of drugs and medical devices in France and negotiations with health authorities. She has also contributed to the definition of the best market access strategies and developed her expertise in market access in various therapeutic areas, including renal therapy, anaesthesia, cardiology, oncology, nutrition, immunology, pneumology, rare diseases and diabetes.

Marion joined MediTech Access in 2016. Her mission is to plan, manage and organise the administrative, financial and accounting activities of the company. She coordinates the proper execution of the strategy and procedures defined with the general management. She is also the advisor to the structure's managers.

With a non-specialist graduate background, Marion began her career in marketing and communication in the media field. Involved in the creation of a small French business start-up, she decided to turn to corporate administration, delivering outsourced services for seven years.

Charles joined MediTech Access in 2016. He started as consultant for various market access and health economic missions in France. Supporting Claire in the management of the team since 2018, he is now also in charge of market access and business development in Belgium and Switzerland.

Pharmacist, Charles holds a Master’s Degree in health economics (Descartes University, Paris) and a university diploma in medical statistics and epidemiology (CESAM, UPMC, Paris). After an internship in Public Health at IGAS (French national government agency), he completed his pharmacy thesis on the RIHN, a national early-funding modality designed to promote innovative in-vitro diagnostics in France. As medical writing expert and early-funding and reimbursement specialist in France, Belgium and Switzerland, he is actively involved in the set up and implementation of strategic market access plans for medical devices, in-vitro diagnostics, medical procedures and e-health, in various therapeutic areas including cardiology, oncology, diabetes, hepato-gastroenterology, urology, vascular diseases, pneumology, orthopaedics and neurology.

Diane joined the MediTech Access team in 2021, as consultant. She is currently working on projects on a national scale, covering various therapeutic areas, contributing to the valorisation of medical devices, digital health products, as well as their associated medical procedures or services.

Diane is a pharmacist. She has acquired a Master's degree in Market Access & Health Economics Outcomes Research from the University of Paris-Saclay. She completed her pharmacy thesis on biosimilars Market Access in France. During her education, she acquired the required skills for the management of pricing and reimbursement projects. She strengthened that knowledge and developed transversal abilities on life cycle management on a worldwide scope during a one-year-and-a-half experience in Global Market Access in Sanofi.